Nobody is going to buy vvus unless they get the approval for their weight loss drug which in in mid July. Without the approval, vvus is worth not more than $7. Everything between $7 and $24 (current price) is hype. If they get the approval in July (which they might get, 80% chance IMO), a buy-out would be in cards. Until then, be happy with $20/share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.